Mycobacterium tuberculosis survives and multiplies inside macrophages of its host by modulating the expression of several genes essential for in vivo survival. An in vivo expression system has been developed, based on green fluorescent protein and kanamycin resistance, to identify M. tuberculosis genes which appear to be up-regulated in infected macrophages. A promoter-trap shuttle vector, pLL192, was constructed, containing a streptomycin resistance gene as selection marker and an artificial bicistronic operon composed of the promoterless green fluorescent protein (gfp) gene, followed by the kanamycin resistance gene. A unique BamHI site upstream of the gfp gene allowed for insertion of promoter libraries. The vector was validated by the use of known regulated or constitutive M. tuberculosis promoters. In addition, an M. tuberculosis genomic DNA library was inserted into pLL192 and then introduced into Mycobacterium bovis BCG. The recombinant BCG cells were then used to infect the J774A.1 murine macrophage-like cell line in the presence of kanamycin. Several recombinant BCG cells were thereby selected that were resistant to kanamycin within infected macrophages, but were sensitive to kanamycin when grown in vitro. The kanamycin resistance phenotype was paralleled by the fluorescence phenotype. After nucleotide sequencing, the corresponding genes were identified as mce1A, PE_PGRS63(RV3097c), Rv2232, Rv1026, Rv1635c, viuB, Rv2231(cobC) and Rv0997. Real-time PCR analysis using RNA isolated at various time points from M. tuberculosis and M. bovis BCG grown in vitro and within macrophages, confirmed the up-regulation of these genes. The level of up-regulation varied from 2- to 40-fold in macrophages compared to growth in vitro.
ArrudaS., BomfimG., KnightsR., Huima-ByronT.,
RileyL. W.1993; Cloning of an Mycobacterium tuberculosis DNA fragment associated with entry and survival inside cells. Science 261:1454–1457[CrossRef]
BarkerL. P., BrooksD. M.,
SmallP. L. C.1998; The identification of Mycobacterium marinum genes differentially expressed in macrophage phagosomes using promoter fusions to green fluorescent protein. Mol Microbiol 29:1167–1177[CrossRef]
ButtertonJ. R.,
CalderwoodS. B.1994; Identification, cloning, and sequencing of a gene required for ferric vibriobactin utilization by Vibrio cholerae . J Bacteriol 176:5631–5638
CamachoL. R., EnsergueixD., PerezE., GicquelB.,
GuilhotC.1999; Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol Microbiol 34:257–267[CrossRef]
DebD. K., DahiyaP., SrivastavaK. K., SrivastavaR.,
SrivastavaB. S.2002; Selective identification of new therapeutic targets of Mycobacterium tuberculosis by IVIAT approach. Tuberculosis (Edinb) 82:175–182[CrossRef]
GrahamJ. E.,
Clark-CurtissJ. E.1999; Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences (SCOTS. Proc Natl Acad Sci U S A 96:11554–11559[CrossRef]
HarthG.,
HorwitzM. A.1999; An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: extracellular proteins as potential novel drug targets. J Exp Med 189:1425–1436[CrossRef]
HobsonR. J., McBrideA. J., KempsellK. E.,
DaleJ. W.2002; Use of an arrayed promoter-probe library for the identification of macrophage-regulated genes in Mycobacterium tuberculosis . Microbiology 148:1571–1579
KremerL., BaulardA., EstaquierJ., Poulain-GotefroyO.,
LochtC.1995; Green fluorescent protein as a new expression marker in mycobacteria. Mol Microbiol 17:913–922[CrossRef]
LivakK. J.,
SchmittgenT. D.2001; Analysis of relative gene expression data using real-time quantitative PCR and the Method. Methods 25:402–408[CrossRef]
MahanM. J., SlauchJ. M.,
MekalanosJ. J.1993; Selection of bacterial virulence genes that are specifically induced in host tissues. Science 259:686–688[CrossRef]
MaurinM.,
RaoultD.2001; Use of aminoglycosides in treatment of infections due to intracellular bacteria. Antimicrob Agents Chemother 45:2977–2986[CrossRef]
PaytonM., AutyR., DelgodaR., EverettM.,
SimE.1999; Cloning and characterization of arylamine N -acetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis : increased expression results in isoniazid resistance. J Bacteriol 181:1343–1347
SassettiC. M., BoydD. H.,
RubinE. J.2003; Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol 48:77–84[CrossRef]
SaviolaB., WoolwineS. C.,
BishaiW. R.2003; Isolation of acid-inducuble genes of Mycobacterium tuberculosis with the use of recombinase-based in vivo expression technology. Infect Immun 71:1379–1388[CrossRef]
StoverC. K., de la CruzV. F., FuerstT. R., BurleinJ. E., BensonL. A., BennettL. T., BansalG. P., YoungJ. F., LeeM. H.other authors1991; New use of BCG for recombinant vaccines. Nature 351:456–460[CrossRef]
TalaatA. M., LyonsR., HowardS. T.,
JohnstonS. A.2004; The temporal expression profile of Mycobacterium tuberculosis infection in mice. Proc Natl Acad Sci U S A 101:4602–4607[CrossRef]
TriccasJ. A., BerthetF. X., PelicicV.,
GicquelB.1999; Use of fluorescence induction and sucrose counterselection to identify Mycobacterium tuberculosis genes expressed within host cells. Microbiology 145:2923–2930
WHO1997Anti-tuberculosis drug resistance in the world. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 1994–1997 (WHO/TB/97.229) Geneva: World Health Organization;
YuanY., CraneD. D., SimpsonR. M., ZhuY. Q., HickeyM. J., ShermanD. R.,
BarryC. E.III1998; The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages. Proc Natl Acad Sci U S A 95:9578–9583[CrossRef]